Viewing data from:

ANEXSIA 5/325

ANDA

ACETAMINOPHEN; HYDROCODONE BITARTRATE | A040409 | SPECGX LLC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 5 NDCs

Highest NADAC/Unit

$0.1351

per ea

Lowest NADAC/Unit

$0.1351

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00406012301HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET	$0.1351	EA	Generic	—	2026-06-17
00406012305HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET	$0.1351	EA	Generic	—	2026-06-17
00406012310HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET	$0.1351	EA	Generic	—	2026-06-17
00406012323HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET	$0.1351	EA	Generic	—	2026-06-17
00406012362HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET	$0.1351	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$8.11

Highest Price

$39.48

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00406-0123-01HYDROCODONE 5MG/ACETAMINOPHEN 325MG TAB	$8.11	FSS	SpecGx LLC	09/14/2027
00406-0123-05HYDROCODONE 5MG/ACETAMINOPHEN 325MG TAB	$39.48	FSS	SpecGx LLC	09/14/2027
00406-0123-62HYDROCODONE 5MG/ACETAMINOPHEN 325MG TAB	$25.95	FSS	SpecGx LLC	09/14/2027

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Oct 20, 2000	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 325MG;5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Oct 20, 2000

No patent or exclusivity listings for this strength.